浅析新冠肺炎肝损伤的发病机制
Analysis of the Pathogenesis of Liver Injury Caused by COVID-19
DOI: 10.12677/ACM.2022.125677, PDF,    国家自然科学基金支持
作者: 张美玲*, 王祯芝, 熊 康, 李 雄:陕西中医药大学,陕西 咸阳;雷根平, 董 盛, 周 锋#:陕西中医药大学附属医院,陕西 咸阳
关键词: 新型冠状病毒肺炎肝损伤发病机制COVID-19 Liver Injury Pathogenesis
摘要: 2019冠状病毒病(Coronavirus Disease 2019, COVID-19)引起肝脏损伤在临床中并不少见。目前认为新冠肺炎发生肝损伤的原因与病毒、炎症、药物、低氧等密切相关。本文通讯作者通过观察研究武汉、西安等地的气候特点、人群发病特征,从现代医学角度总结发现慢性心理应激、肠道功能、肾素–血管紧张素系统(Renin-Angiotensin System, RAS)、凝血机制也会引发肝损伤;从传统中医角度认为通过解剖毗邻、经络相通、气血升降、五行克侮、五脏一体观等引发肝损伤。进一步总结发现新冠肝损伤对于认识病毒及其发病机制、提高临床诊治效率具有重要研究意义,为后续研究新冠肝损伤的机制、治疗、预后提供重要线索。
Abstract: Liver damage caused by Coronavirus Disease 2019 (COVID-19) is not uncommon in the clinic. It is currently believed that the causes of liver damage caused by COVID-19 are closely related to virus-es, inflammation, drugs and hypoxia. In this paper, the corresponding author observed and studied the climate characteristics and population morbidity characteristics in Wuhan and Xi’an, and con-cluded from the perspective of modern medicine that chronic psychological stress, intestinal func-tion, Renin-Angiotensin System (RAS) and coagulation mechanism can also cause liver injury. From the perspective of traditional Chinese medicine, it is believed that liver injury can be caused by an-atomical adjacency, interlinking of channels and collaterals, rising and falling of qi and blood, the five elements and the five visceraorganic whole. In conclusion, it is of great research significance to understand the virus and its pathogenesis, improve the efficiency of clinical diagnosis and treat-ment, and provide important clues for the follow-up study on the mechanism, treatment and prog-nosis of liver injury of COVID-19.
文章引用:张美玲, 王祯芝, 熊康, 李雄, 雷根平, 董盛, 周锋. 浅析新冠肺炎肝损伤的发病机制[J]. 临床医学进展, 2022, 12(5): 4680-4685. https://doi.org/10.12677/ACM.2022.125677

参考文献

[1] Yuki, K., Fujiogi, M. and Koutsogiannaki, S. (2020) COVID-19 Pathophysiology: A Review. Clinical Immunology, 215, Article ID: 108427. [Google Scholar] [CrossRef] [PubMed]
[2] Araf, Y., Faruqui, N.A., Anwar, S., et al. (2021) SARS-CoV-2: A New Dimension to Our Understanding of Coronaviruses. International Microbiology, 24, 19-24. [Google Scholar] [CrossRef] [PubMed]
[3] Li, S.R., Tang, Z.J., Li, Z.H., et al. (2020) Searching Therapeutic Strategy of New Coronavirus Pneumonia from Angiotensin-Converting Enzyme 2: The Target of COVID-19 and SARS-CoV. European Journal of Clinical Microbiology & Infectious Diseases, 39, 1021-1026. [Google Scholar] [CrossRef] [PubMed]
[4] Ciotti, M., Ciccozzi, M., Terrinoni, A., et al. (2020) The COVID-19 Pandemic. Critical Reviews in Clinical Laboratory Sciences, 57, 365-388. [Google Scholar] [CrossRef] [PubMed]
[5] Xu, L., Liu, J., Lu, M., Yang, D. and Zheng, X. (2020) Liver Injury during Highly Pathogenic Human Coronavirus infections. Liver International, 40, 998-1004. [Google Scholar] [CrossRef] [PubMed]
[6] Chai, X., Hu, L., Zhang, Y., et al. (2020) Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage after 2019-nCoV Infection. BioRxiv. [Google Scholar] [CrossRef
[7] Lei, F., Liu, Y.M., Zhou, F., et al. (2020) Longitudinal Associa-tion between Markers of Liver Injury and Mortality in COVID‐19 in China. Hepatology, 72, 389-398. [Google Scholar] [CrossRef] [PubMed]
[8] Wang, Y., Liu, S., Liu, H., et al. (2020) SARS-CoV-2 Infection of the Liv-er Directly Contributes to Hepatic Impairment in Patients with COVID-19. Journal of Hepatology, 73, 807-816. [Google Scholar] [CrossRef] [PubMed]
[9] Fan, Z., Chen, L., Li, J., et al. (2020) Clinical Features of COVID-19-Related Liver Functional Abnormality. Clinical Gastroenterology and Hepatology, 18, 1561-1566. [Google Scholar] [CrossRef] [PubMed]
[10] Feng, G., Zheng, K.I., Yan, Q.Q., et al. (2020) COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies. Journal of Clinical and Translational Hepa-tology, 8, 18-24. [Google Scholar] [CrossRef
[11] Gao, R.Y., Wang, M., Liu, Q., et al. (2020) Hypoxia‐Inducible Factor‐2α Reprograms Liver Macrophages to Protect Against Acute Liver Injury through the Production of Interleukin‐6. Hepatology, 71, 2105-2117. [Google Scholar] [CrossRef] [PubMed]
[12] Cai, Q., Huang, D., Yu, H., et al. (2020) COVID-19: Abnormal Liver Function Tests. Journal of Hepatology, 73, 566- 574. [Google Scholar] [CrossRef] [PubMed]
[13] Ali, N. (2020) Relationship between COVID-19 Infection and Liver Injury: A Review of Recent Data. Frontiers in Medicine, 7, Article No. 458. [Google Scholar] [CrossRef] [PubMed]
[14] 李晓骄阳, 李雅静, 葛俊德, 吴恺懌, 孙蓉. 注重新型冠状病毒肺炎(COVID-19)治疗中药物性肝损伤的预警与保护[J]. 中草药, 2020, 51(4): 851-859.
[15] 穆杰, 纪文婷, 任北大, 连雅君, 杜欣, 王雪茜, 等. 肝气郁结在神经-代谢层面引起肝损伤的病理机制[J]. 中华中医药杂志, 2020, 35(3): 1194-1198.
[16] 李果. 交感神经经β肾上腺素能受体途径调控急性肝损伤的研究[D]: [硕士学位论文]. 第三军医大学, 2012.
[17] 钱令嘉. 应激生理学-生命维护和疾病控制的重要领域[J]. 生理科学进展, 2013, 44(5): 321-322
[18] 宦宏波, 夏锋, 吴林, 吴黎雳, 邓翔, 马宽生, 等. 肝脏去交感神经状态对大鼠脂类和激素代谢的影响[J]. 实用临床医药杂志, 2014, 18(9): 1-5.
[19] Lei, H.Y., Ding, Y.H., Nie, K., et al. (2021) Poten-tial Effects of SARS-CoV-2 on the Gastrointestinal Tract and Liver. Biomedicine & Pharmacotherapy, 133, Article ID: 111064. [Google Scholar] [CrossRef] [PubMed]
[20] Sharma, L. and Riva, A. (2020) Intestinal Barrier Func-tion in Health and Disease—Any Role of Sars-Cov-2? Microorganisms, 8, Article No. 1744. [Google Scholar] [CrossRef] [PubMed]
[21] Ghosh, S.S., Wang, J., Yannie, P.J., et al. (2020) Intestinal Barrier Function and Metabolic/Liver Diseases. Liver Research, 4, 81-87. [Google Scholar] [CrossRef
[22] 刘颖, 王凯, 纪晓霞, 等. 肾素血管紧张素系统(RAS)两条轴相互负向调节与大鼠非酒精性脂肪肝病(NAFLD)肝损伤的关系研究[J]. 畜牧与兽医, 2019, 51(5): 48-54.
[23] Santos, R.A.S., Sampaio, W.O., Alzamora, A.C., et al. (2018) The ACE2/Angiotensin-(1-7)/Mas Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7). Physiological Reviews, 98, 505-553. [Google Scholar] [CrossRef] [PubMed]
[24] Tsutsumi, T., Saito, M., Nagai, H., et al. (2021) Association of Coagulopathy with Liver Dysfunction in Patients with COVID‐19. Hepatology Research, 51, 227-232. [Google Scholar] [CrossRef] [PubMed]
[25] Amitrano, L., Guardascione, M.A., Brancaccio, V., et al. (2002) Coagula-tion Disorders in Liver Disease. Seminars in Liver Disease, 22, 83-96. [Google Scholar] [CrossRef] [PubMed]
[26] Mammen, E.F. (1994) Coagulation Defects in Liver Disease. Medical Clinics of North America, 78, 545-554. [Google Scholar] [CrossRef
[27] Chen, S., Liu, H., Li, T., et al. (2020) Correlation Analysis of Coagulation Dysfunction and Liver Damage in Patients with Novel Coronavirus Pneumonia: A Single-Center, Retro-spective, Observational Study. Upsala Journal of Medical Sciences, 125, 293-296. [Google Scholar] [CrossRef] [PubMed]
[28] 姜慧, 齐向华, 滕晶. 吴又可《瘟疫论》理论辨析新型冠状病毒肺炎[J]. 四川中医, 2020, 38(3): 12-14.
[29] 姚荷生, 潘佛巖, 廖家兴. 脏象学说与诊断应用的文献探讨-脾脏、肝脏、肺脏[M]. 北京: 人民卫生电子音像出版社, 2014: 28.